Get the Stockscreener App
0.60
1.62%
-0.0099
After Hours:
.61
0.01
+1.67%
Xortx Therapeutics Inc stock is traded at $0.60, with a volume of 31,952.
It is down -1.62% in the last 24 hours and down -4.90% over the past month.
XORTX Therapeutics Inc is a clinical-stage biotechnology company focused on identifying, developing, and potentially commercializing therapies to treat progressive kidney disease modulated by aberrant purine and uric acid metabolism and uric acid metabolism in orphan (rare) disease indications such as ADPKD and T2DN, as well as AKI associated with respiratory virus infection. Its focus is on developing three therapeutic products to slow or reverse the progression of chronic kidney disease, address the immediate need of individuals facing AKI associated with respiratory virus infection, and identify other opportunities where existing and new intellectual property can be leveraged to address health issues.
See More
Previous Close:
$0.6099
Open:
$0.61
24h Volume:
31,952
Relative Volume:
0.02
Market Cap:
$4.18M
Revenue:
-
Net Income/Loss:
$-736.70K
P/E Ratio:
-60.00
EPS:
-0.01
Net Cash Flow:
$-4.14M
1W Performance:
+7.14%
1M Performance:
-4.90%
6M Performance:
-33.34%
1Y Performance:
-54.20%
1-Day Range:
$0.5866
$0.615
1-Week Range:
$0.56
$0.615
52-Week Range:
$0.51
$1.79
Xortx Therapeutics Inc Stock (XRTX) Company Profile
Compare XRTX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
XRTX
Xortx Therapeutics Inc
|
0.60 | 4.25M | 0 | -736.70K | -4.14M | -0.01 |
|
VRTX
Vertex Pharmaceuticals Inc
|
468.38 | 113.87B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
776.54 | 80.22B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
406.40 | 52.56B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
803.74 | 49.31B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
175.07 | 37.37B | 447.02M | -1.18B | -906.14M | -6.1812 |
Xortx Therapeutics Inc Stock (XRTX) Latest News
XORTX Therapeutics Inc. (XRTX) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
XORTX Leans Into Genetic Breakthroughs in Gout as It Reshapes Board and Advances Oxypurinol - TipRanks
Huge gout genetics study highlights target in kidney disease research - Stock Titan
XORTX Announces USD $3 Million Offering - 富途牛牛
Multi Factor Analysis Ranks Jaihind Synthetics Limited as Strong BuyInsider Selling Patterns & Lower Drawdowns With Smart Position Sizing - bollywoodhelpline.com
Order Book Volume Tilts Bullish on Adani Wilmar LimitedCurrency Fluctuation Impact & Breakout Stock Alerts - bollywoodhelpline.com
Chart Analysts Warn of Resistance Near Glance Finance Limited PriceCapital Gains Strategies & Small Capital Trading Plans - bollywoodhelpline.com
Fibonacci Levels Suggest Recovery for Johnson Pharmacare LimitedMomentum Trading Signals & Analysts Are Raving About These Shares - bollywoodhelpline.com
Global Longlife Hospital and Research Limited (543520) Sees Unusual Trading VolumeFinancial Sector Performance & Small Entry Cost Trading - bollywoodhelpline.com
Can Fabino Life Sciences Limited Bounce Back From Weekly LowEx-Dividend Date Alerts & Outstanding Investment Returns - bollywoodhelpline.com
Will XORTX Therapeutics Inc. stock beat EPS estimatesVolume Profile Analysis & Superior Wealth Building - Bollywood Helpline
What drives XORTX Therapeutics Inc stock priceEconomic Data Impact & Free Stock Market Mentorship Programs - earlytimes.in
Aug Decliners: Why XORTX Therapeutics Inc. stock is in analyst buy zoneJuly 2025 Sector Moves & Fast Gaining Stock Reports - ulpravda.ru
How XORTX Therapeutics Inc. stock reacts to inflationary pressures2025 Fundamental Recap & Free Real-Time Market Sentiment Alerts - Улправда
Why XORTX Therapeutics Inc. (ANUA) stock could be top winnerJuly 2025 Snapshot & Verified Entry Point Signals - Улправда
Why XORTX Therapeutics Inc. stock is in analyst buy zoneJuly 2025 Pullbacks & Real-Time Market Sentiment Reports - Улправда
Is XORTX Therapeutics Inc. stock positioned well for digital economy2025 Price Targets & Scalable Portfolio Growth Methods - Улправда
Growth Value: Is XORTX Therapeutics Inc. stock positioned well for digital economyJuly 2025 Snapshot & Low Drawdown Trading Techniques - Улправда
Will XORTX Therapeutics Inc. stock attract ESG investorsCEO Change & Daily Technical Forecast Reports - Улправда
What technical charts say about XORTX Therapeutics Inc. stockStock Surge & Accurate Intraday Trading Signals - Улправда
Will XORTX Therapeutics Inc. stock attract more institutional investors2025 Bull vs Bear & Weekly Momentum Stock Picks - DonanımHaber
Certain Stock Options of XORTX Therapeutics Inc. are subject to a Lock-Up Agreement Ending on 14-DEC-2025. - marketscreener.com
Aug Analyst Calls: Will XORTX Therapeutics Inc stock attract ESG investorsJuly 2025 Chart Watch & Growth Focused Stock Reports - BỘ NỘI VỤ
XORTX Therapeutics Announces US$1.1 Million Direct Offering - MSN
XORTX Therapeutics (XRTX) Stock Analysis Report | Financials & Insights - Benzinga
Can XORTX Therapeutics Inc. (ANUA) stock deliver strong annual returnsMarket Risk Analysis & Safe Entry Zone Tips - Newser
Is XORTX Therapeutics Inc. stock a defensive play in 2025Weekly Earnings Recap & Stepwise Swing Trade Plans - Newser
Is XORTX Therapeutics Inc. (ANUA) stock a buy for dividend portfoliosEarnings Risk Report & Free Real-Time Volume Trigger Notifications - Newser
Why XORTX Therapeutics Inc. (ANUA) stock could outperform next yearJuly 2025 Outlook & Daily Volume Surge Signals - Newser
Why XORTX Therapeutics Inc. stock could see breakout soonJuly 2025 Drop Watch & Accurate Buy Signal Alerts - Newser
Will XORTX Therapeutics Inc. stock deliver strong dividend growthWeekly Stock Report & High Accuracy Swing Trade Signals - Newser
How XORTX Therapeutics Inc. (ANUA) stock reacts to stronger dollar2025 Bull vs Bear & Risk Adjusted Buy and Sell Alerts - Newser
Can XORTX Therapeutics Inc. stock outperform in 2025 bull marketJuly 2025 Gainers & Capital Protection Trading Alerts - Newser
Is XORTX Therapeutics Inc. (ANUA) stock a buy before new product rolloutJuly 2025 Selloffs & Risk Controlled Daily Plans - Newser
Will AI Trends Push Aditya Vision Limited Stock Even HigherLarge Cap Stability Picks & Explosive Profit Trading - earlytimes.in
Xortx Therapeutics Inc Stock (XRTX) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.52%
0.07%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):